Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism: Reply

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 12, 2014, Pages 2138-2139

  van der Hulle, T ^a   Huisman, M V ^a   Klok, F A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADVANCED CANCER; BLEEDING; CANCER ASSOCIATED ACUTE VENOUS THROMBOEMBOLISM; CANCER PATIENT; CLINICAL PRACTICE; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; META ANALYSIS (TOPIC); NEOPLASM; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; COMPLICATION; VENOUS THROMBOSIS;

ANTICOAGULANTS; HUMANS; NEOPLASMS; VENOUS THROMBOSIS;

EID: 84916599563     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12758     Document Type: Letter

References (3)

1. van der Hulle T, den Exter PL, Kooiman J, van der Hoeven JJ, Huisman MV, Klok FA. Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism. J Thromb Haemost 2014; 12: 1116-20.
2. Di Minno MN, Ageno W, Dentali F. Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism: comment. J Thromb Haemost 2014. doi: 10.1111/jth.12746 [Epub ahead of print].
3. Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 146-53.